Financials HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:59 30/04/2024 BST			5-day change	1st Jan Change
186.4 ^CHF	+0.32%		+0.43%	+2.08%

04-03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
01-22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Fiscal Period: März	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,159	1,320	2,313	1,920	1,489	1,288	-	-
Enterprise Value (EV) ¹	1,159	1,320	2,409	2,064	1,632	1,256	1,235	1,213
P/E ratio	-	7.24 x	3.06 x	-24.6 x	-10.2 x	-18 x	77 x	12.7 x
Yield	4.44%	4.05%	3.76%	3.51%	3.5%	4.02%	3.02%	3.02%
Capitalization / Revenue	-	-	-	-51.2 x	-12.8 x	-30.4 x	27.9 x	9.83 x
EV / Revenue	-	-	-	-55 x	-14 x	-29.6 x	26.8 x	9.26 x
EV / EBITDA	-	7.13 x	3.18 x	-27.4 x	-11.2 x	-17.8 x	68.6 x	11.8 x
EV / FCF	-	-20.6 x	43.2 x	-34.3 x	18.3 x	661 x	20 x	19.6 x
FCF Yield	-	-4.86%	2.31%	-2.92%	5.46%	0.15%	5.01%	5.1%
Price to Book	0.89 x	1.01 x	1.08 x	0.97 x	0.84 x	0.79 x	0.8 x	0.77 x
Nbr of stocks (in thousands)	6,865	6,947	6,957	6,957	6,957	6,911	-	-
Reference price ²	168.8	190.0	332.5	276.0	214.0	186.4	186.4	186.4
Announcement Date	16/05/19	08/05/20	27/05/21	18/05/22	26/05/23	-	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: März	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	-	-	-37.5	-116.5	-42.4	46.1	131
EBITDA ¹	-	185.1	758.7	-75.31	-146.1	-70.4	18	103
EBIT ¹	-	185.1	758.7	-75.31	-146.1	-70.4	18	103
Operating Margin	-	-	-	200.85%	125.35%	166.04%	39.05%	78.63%
Earnings before Tax (EBT) ¹	-	182.7	756.3	-78.03	-145.3	-71.7	18	103
Net income ¹	-	183	756.3	-78.03	-145.3	-71.7	18	103
Net margin	-	-	-	208.1%	124.67%	169.1%	39.05%	78.63%
EPS ²	-	26.26	108.7	-11.22	-20.98	-10.35	2.420	14.68
Free Cash Flow ¹	-	-64.16	55.77	-60.2	89.12	1.9	61.9	61.9
FCF margin	-	-	-	160.54%	-76.48%	-4.48%	134.27%	47.25%
FCF Conversion (EBITDA)	-	-	7.35%	-	-	-	343.89%	60.1%
FCF Conversion (Net income)	-	-	7.37%	-	-	-	343.89%	60.1%
Dividend per Share ²	7.500	7.700	12.50	9.700	7.500	7.500	5.620	5.620
Announcement Date	16/05/19	08/05/20	27/05/21	18/05/22	26/05/23	-	-	-

¹CHF in Million²CHF

Estimates

Fiscal Period: März	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	96.2	144	143	-	-	-
Net Cash position ¹	-	-	-	-	-	32	53	75
Leverage (Debt/EBITDA)	-	-	0.1268 x	-1.906 x	-0.982 x	-	-	-
Free Cash Flow ¹	-	-64.2	55.8	-60.2	89.1	1.9	61.9	61.9
ROE (net income / shareholders' equity)	-	-	-	-	-	-4.4%	-	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	189.0	188.0	309.0	286.0	255.0	237.0	234.0	243.0
Cash Flow per Share	-	-	-	-	-	-	-	-
Capex	-	-	-	-	-	-	-	-
Capex / Sales	-	-	-	-	-	-	-	-
Announcement Date	16/05/19	08/05/20	27/05/21	18/05/22	26/05/23	-	-	-

¹CHF in Million²CHF

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

D+

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

186.4 CHF

Average target price

236 CHF

Spread / Average Target

+26.61%

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+2.08%	1.41B
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+15.78%	3.06B
OCTOPUS TITAN VCT PLC	-8.46%	1.23B
MOLTEN VENTURES PLC	+1.77%	658M
VERUSA HOLDING	+45.05%	617M
CION INVESTMENT CORPORATION	+0.71%	615M
OCTOPUS APOLLO VCT PLC	-4.17%	495M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+30.43%	473M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	306M